India described as totally irrational’ a report that a new superbug resistant to antibiotics originated from the country and strongly protested a British alert in this regard. Director General of Indian Council for Medical Research V M Katoch and Director General of Health Services R K Srivastava strongly objected the naming of the enzyme as New Delhi metallo beta lactamase and also refuted that hospitals in India are not safe for treatment including medical tourism. The Health Ministry came out with a hard-hitting statement after a study published in scientific journal 'Lancet', said the new superbug, which is said to be resistant even to most powerful antibiotics, has entered UK hospitals and is travelling with patients who had gone to countries like India and Pakistan for surgical treatments. The issue was also raised in the Rajya Sabha by members who suspected the hands of multi-national pharmaceutical companies and hospital chains behind the scientists' claim.